Neurocrine Biosciences (NBIX) Interest Coverage Ratio (2011 - 2026)

Neurocrine Biosciences' Interest Coverage Ratio history runs 15 years deep, the most recent figure standing at 0.33 for Q1 2026.

• Quarterly Interest Coverage Ratio fell 87.09% year-over-year to 0.33 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.34 (down 92.87% YoY) and the FY2025 annual result came in at 6.36, up 25.14% from the prior year.
• Interest Coverage Ratio was 0.33 for Q1 2026 at Neurocrine Biosciences, down from 5.58 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 79.11 in Q4 2023 and bottomed at 18.46 in Q4 2022.
• A 5-year average of 14.33 and a median of 3.08 in 2023 frame the typical range for Interest Coverage Ratio.
• Peak annual rise in Interest Coverage Ratio reached 985.17% in 2022, while the deepest fall reached 993.61% in 2022.
• Neurocrine Biosciences' Interest Coverage Ratio stood at 18.46 in 2022, then surged by 528.42% to 79.11 in 2023, then tumbled by 80.27% to 15.6 in 2024, then sank by 64.24% to 5.58 in 2025, then sank by 94.13% to 0.33 in 2026.
• Business Quant data shows NBIX's Interest Coverage Ratio at 0.33 in Q1 2026, 5.58 in Q4 2025, and 0.39 in Q3 2025.